Comparison of Omeprazole and Ranitidine in the Treatment of Reflux Esophagitis

New England Journal of Medicine

Volumn 314, Issue 11, 1986, Pages 716-

  Blum, A L ^a   Riecken, E O ^b   Dammann, H G ^c   Schiessel, R ^d   Lux, G ^e   Wienbeck, M ^f   Rehner, M ^g   Witzel, L ^h  

^a TRIEMLI HOSPITAL   (Switzerland)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Krankenhaus Bethanien   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g Department of Medicine Medical Oncology and Hematology Gastroenterology and Infectious Disease   (Germany)

^h DRK Klinik Mark Brandenburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; RANITIDINE;

CLINICAL ARTICLE; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; EDITORIAL; ESOPHAGUS; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; THERAPY;

ANIMALS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CLINICAL TRIALS; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; FEMALE; HUMANS; OMEPRAZOLE; RANDOM ALLOCATION; RANITIDINE; RATS;

EID: 0022648282     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198603133141116     Document Type: Letter

References (9)

1. Wesdorp E, Bartelsman J, Papa K, Dekker W, Tytgat GN. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978; 74: 821–4.
2. Lepsien G, Sonnenberg A, Berges W, et al. Die Behandlung der Refluxösophagitis mit Cimetidin. Dtsch Med Wochenschr 1979; 104: 901–6.
3. Brown P. Cimetidine in the treatment of reflux oesophagitis. Med J Aust 1979; 2: 96–7.
4. Wesdorp ICE, Dekker W, Klinkenberg-Knol EC. Treatment of reflux oesophagitis with ranitidine. Gut 1983; 24: 921–4.
5. Koelz HR, Birchler R, Bron B, et al. Behandlung der Refluxösophagitis mit Ranitidin: eine multizentrische prospektive Studie. Schweiz Med Wochenschr 1982; 112: 1901–4.
6. Grove O, Bekker C, Jeppe-Hanssen MG, et al. Ranitidine and high-dose antacid in reflux oesophagitis: a randomized, placebo-controlled trial. Scand J Gastroenterol 1985; 20: 457–61.
7. Fimmel CJ, Etienne A, Cilluffo T, et al. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. Gastroenterology 1985; 88: 1842–51.
8. Dammann HG, Müller P, Seitz HK, Simon B. Såuresekretionsverhalten unter einer mehrtågigen Omeprazol-Gabe. Schweiz Med Woschenschr 1983; 113: 895–8.
9. Håkanson R, Sundler F, Carlsson E, Mattson H, Larsson H. Proliferation of enterochromaffin-like (ECL) cells in the rat stomach following omeprazole treatment. Hepatogastroenterology 1985; 32: 48–9.